|AI-formulated medicine to be tested on humans for the first time |
A drug designed entirely by artificial intelligence is about to enter clinical human trials for the first time. The drug, which is intended to treat obsessive-compulsive disorder, was discovered using AI systems from Oxford-based biotech company Exscientia. While it would usually take around four and a half years to get a drug to this stage of development, Exscientia says that by using the AI tools it's taken less than 12 months.
The drug, known as DSP-1181, was created by using algorithms to sift through potential compounds, checking them against a huge database of parameters, including a patient's genetic factors. Speaking to the BBC, Exscientia chief executive Professor Andrew Hopkins described the trials as a "key milestone in drug discovery" and noted that there are "billions" of decisions needed to find the right molecules for a drug, making their eventual creation a "huge decision." With AI, however, "the beauty of the algorithm is that they are agnostic, so can be applied to any disease."
Read More - Engadget